Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease

Trial Phase 2 Completed May 27, 2014

A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients

Trial Phase 3 Completed May 22, 2014

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

Trial Phase 2 Completed May 22, 2014

Anesthesia for Deep Brain Stimulation

Trial Phase 4 Completed May 19, 2014

A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease

Trial Phase 3 Completed May 19, 2014

Non-motor Symptoms (Depressive Symptoms) of Parkinson's Disease and Their Course Under Pramipexole Treatment

Trial N/A Completed May 19, 2014

Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD

Trial Phase 3 Completed May 15, 2014

A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients

Trial Phase 4 Completed May 15, 2014

Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Trial Phase 3 Completed May 15, 2014

a PMS on Safety Profile of Pramipexole in Chinese Parkinson Disease Patients

Trial N/A Completed May 15, 2014

Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease (PD)

Trial Phase 4 Completed May 15, 2014

Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease

Trial Phase 3 Completed May 15, 2014

Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial

Trial Phase 3 Completed May 8, 2014

Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease

Trial Phase 2 Completed May 8, 2014

Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families

Trial Phase 2 Completed May 8, 2014

Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms

Trial Phase 4 Completed May 8, 2014

Relaxation Guided Imagery for Treatment of Parkinson's Disease

Trial Early Phase 1 Completed May 7, 2014

Evaluation of 5-[123I]-A-85380 and SPECT Imaging in Individuals With Parkinsons Disease

Trial Phase 2 Completed May 6, 2014

Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease

Trial Phase 2 Completed May 6, 2014

Famotidine for Levodopa-induced Dyskinesia in PD

Trial Phase 2 Completed May 4, 2014